Advertisement
AIM ImmunoTech Inc. (AIM)
AMEX: AIM
· Real-Time Price · USD
0.09
-0.03 (-23.53%)
At close: Apr 04, 2025, 10:10 AM
13F Institute Ownership
Total Institutes of 34 in AIM ImmunoTech expanded their positions with an increase of 3 investors compared to the previous quarter. A reduction of 4.37M shares, as total invested capital declined by $1.51M with ownership percentage dropping from 15.63% to 8.06%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Vanguard Group Inc | 3.45% | 1.99M | +0.00% | 393.76K | < 0.01% |
| Blackrock, Inc. | 1.21% | 698.27K | +0.00% | 138.26K | < 0.01% |
| Geode Capital Management, LLC | 0.80% | 464.02K | +0.00% | 91.91K | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.